RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
Stock Information for Redhill Biopharma Ltd.
Loading
Please wait while we load your information from QuoteMedia.